Moderna‘s (NASDAQ:MRNA | MRNA Price Prediction) push into cancer treatment is drawing heavy buying as a closely followed ...
Despite a U.S. factory mixup, more Johnson & Johnson doses are becoming available in the U.S., marking the only single-shot vaccine option. So how effective is it and how does it compare to the Pfizer ...
Moderna's NASDAQ 100 debut triggered a surge in buying, but the real question is whether the rally holds once index funds ...
Pfizer (PFE) posted Q4 adjusted EPS of $0.66 beating the $0.57 consensus on $17.56B in revenue while its non-COVID portfolio grew 9% operationally, led by Abrysvo (+136%) and Lorbrena (+45%), plus a ...
The two New Jersey suits assert eight patents against Pfizer and 10 against Moderna, extending existing mRNA litigation beyond delivery technology to manufacturing, purity and non-COVID respiratory ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Mon, May 4, 2026 at 2:09 PM UTC Moderna leaned on cost cuts and international expansion to soften a steep COVID revenue cliff. Two very different pharma stories, both shaped by life after the pandemic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results